Biohaven Ltd. Files 8-K with Regulatory Updates

Ticker: BHVN · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1935979

Biohaven Ltd. 8-K Filing Summary
FieldDetail
CompanyBiohaven Ltd. (BHVN)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, financials

TL;DR

Biohaven Ltd. filed an 8-K on Jan 13, 2025, covering Reg FD and financials. Nothing major revealed yet.

AI Summary

Biohaven Ltd. filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Biohaven Research Ltd. until June 29, 2022, is incorporated in the British Virgin Islands and has its principal executive offices in New Haven, Connecticut.

Why It Matters

This filing provides important updates on Biohaven Ltd.'s regulatory disclosures and financial statements, which are crucial for investors to assess the company's current standing and future prospects.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material adverse events.

Key Players & Entities

  • Biohaven Ltd. (company) — Registrant
  • Biohaven Research Ltd. (company) — Former company name
  • January 13, 2025 (date) — Date of earliest event reported
  • 215 Church Street, New Haven, Connecticut 06510 (location) — Principal executive offices address

FAQ

What specific Regulation FD disclosures are being made by Biohaven Ltd. in this 8-K?

The filing indicates a Regulation FD Disclosure is being made, but the specific details of the disclosure are not provided in the provided text.

What types of financial statements and exhibits are included in this 8-K filing?

The filing states that 'Financial Statements and Exhibits' are included, but the specific nature or content of these documents is not detailed in the provided text.

When did Biohaven Ltd. change its name from Biohaven Research Ltd.?

Biohaven Ltd. changed its name from Biohaven Research Ltd. on June 29, 2022.

Where are Biohaven Ltd.'s principal executive offices located?

Biohaven Ltd.'s principal executive offices are located at 215 Church Street, New Haven, Connecticut, 06510.

What is the Commission File Number for Biohaven Ltd.?

The Commission File Number for Biohaven Ltd. is 001-41477.

Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2025-01-13 11:16:00

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On January 13, 2025, Biohaven Ltd. will be making an investor presentation (the "Presentation"). A copy of the Presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the information set forth in Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Investor Presentation, dated January 2025. 104 The cover page of this Current Report on Form 8-K formatted as Inline XBRL. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 Biohaven Ltd. By: /s/ Matthew Buten Matthew Buten Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.